Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News on Pharma

What is Pi? Covid’s next potential variant that could replace Omicron

After a ‘swarm’ of Omicron subvariants proved mild, scientists are looking to the next possible variant - and it already has a name lined up

The Independent UK

Drugs minister warns of missing needles in life-saving overdose kits

LIFE-saving overdose prevention kits circulating in Scotland could be missing needles after a warning from the UK’s medicine regulator,…

The National (Scotland)

Biogen tabs veteran pharma leader Viehbacher as next CEO

Biogen has picked former Sanofi CEO Christopher Viehbacher to become its next leader, as the drug developer continues to recover from its failed launch of the Alzheimer’s treatment Aduhelm

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

European regulator recommends Pfizer's Omicron booster for children

Pfizer Inc and its partner BioNTech said on Thursday the EU health regulator has recommended authorising the use of their bivalent COVID-19 shot as a booster in children aged 5 through 11.

Reuters

AstraZeneca drops plans for Covid jab approval in US

The drugs giant will instead focus its Covid-19 vaccine efforts elsewhere globally and for its use as a booster.

The Independent UK

High-risk groups top priority for 2023 Covid jabs

Authorities plan to acquire enough Covid-19 vaccines next year initially for 18 million people in high-risk groups, with the number of shots each person will need subject to World Health Organization (WHO) guidance.

Bangkok Post

Is cannabis an effective antibiotic?

Cannabis-based drugs like CBD and THC show surprising potential for defeating antibiotic-resistant germs

Salon

Read news from The Economist, FT, and more,
with one subscription

RSV: Single jab approved for virus that can cause pneumonia in babies

RSV can lead to severe lung issues in very young children including bronchiolitis and pneumonia

The Independent UK

Vaccine advocate, on science, truth, and why he’s not a fan of the latest COVID boosters

PHILADELPHIA -- Philadelphia’s most prominent immunization expert isn’t planning to get the latest COVID-19 booster shot, and doesn’t think most others need to either.

The Philadelphia Inquirer

How long can you test positive for Covid and when are you infectious?

A surge in cases is indicating a new wave has started in the UK

The Independent UK

Nine Covid symptoms affecting the fully vaccinated — and signs you may have it

Fainting and fatigue may signal onset of variant, experts say

The Independent UK

Who can get an autumn Covid booster jab and how do I book?

Booster vaccinations are being offered to everyone in England over the age of 50

The Independent UK

Health department says fifth COVID-19 vaccine doses not being recommended for most people amid rising cases

The Department of Health says fifth doses of a COVID-19 vaccine are not currently being recommended for most people.

ABC News

Dutch, UK fentanyl sellers hit with Treasury sanctions

Two Dutch nationals, an Englishman and nine companies have been targeted for sanctions by the U.S. government for allegedly operating an illegal fentanyl ring that generated millions of dollars in virtual currency

The Independent UK

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Parents urged to support research aimed at protecting babies from RSV infections

Respiratory Syncytial Virus is the leading cause of infant hospital admissions in the UK.

StockNews.com

Is This Biotech Stock a Rising Star in the Making?

Shares of oncology-focused biotechnology company Sonnet BioTherapeutics (SONN) have plummeted more than 70% in price year-to-date due to its poor financials and the broad-based market sell-off. However, the company is advancing its drug candidates via research breakthroughs, clinical trials, and strategic initiatives. Given the company’s constant progress, can this biotech…

Benzinga

EXCLUSIVE: New Partnership Brings Leading Psychedelic Protocol For Alcoholism Treatment To NYC

NYC-based clinics brand Nushama has partnered with Awakn Life Sciences (OTCQB: AWKNF), a clinical-stage psychedelics biotech company to bring

Wales Online

Inhalable and nasal Covid vaccines could trump regular shots

We need to consider a vaccine strategy that will provide longer-term immunity

Get all your
news in one place.

100's of premium titles.
One news app.

Tribune News Service

Pfizer’s COVID cash powers a ‘marketing machine’ on the hunt for new supernovas

For drugmaker Pfizer, a fortune amassed in the COVID pandemic is now paving the path to pharma nirvana: a weight loss pill worth billions.

ABC News

Needle-free COVID-19 vaccine trial begins on the Sunshine Coast in Australian-first

An Australian-first clinical trial for a new needle-free COVID-19 vaccine has begun on the Sunshine Coast, in good news for those who fear the jab.

Wales Online

Pfizer boss labels Covid a 'multibillion-dollar franchise' as vaccine cost set to soar

Chief financial officer David Denton reportedly told investors at the drug maker that he expects profits will continue to rise

Daily Mirror

Breakthrough Covid drug for vulnerable proven to save lives - but it's not free on NHS

Research suggests the drug, called Evusheld, would be 88% effective at preventing intensive care admission for people with weakened immune systems still shielding from Covid because vaccines don't work for them.

Tribune News Service

Widening tech, biotech job cuts could jolt broader Bay Area economy: experts

SAN JOSE, Calif. — Bay Area tech and biotech companies have recently revealed plans to chop thousands of jobs, layoffs that raise the specter that these cutbacks might haunt the region’s broader economy.

Reuters

Novavax says Omicron shot shows strong immune response as second booster

Vaccine maker Novavax Inc said on Tuesday its COVID-19 shot retooled against the Omicron BA.1 variant showed a strong immune response as the fourth dose and met the main goal of strain change in a late-stage study.

The Guardian - UK

Psychedelic drug research held back by UK rules and attitudes, say scientists

Active ingredient of magic mushrooms still classified as having no medical value, despite clinical success

1 … 102 103 104 105

People

Mangeet Kaur BounsMangeet

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

World Health Organization

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.